Daiichi Sankyo sends US QA director to rescue Ranbaxy India ops; FDA urged to mandate closer vaccine scrutiny;

> Japan's Daiichi Sankyo has named U.S. QA director Dale Adkisson to oversee the quality and manufacturing efforts at Ranbaxy Labs in India, one of the FDA's GMP violation poster children. Article

> Following the rotavirus contamination, the FDA is being urged to require checks for barely detectable biological matter in vaccine-making. Article

> Anika Therapeutics says the FDA has OK'd corrective actions following a 2008 GMP warning letter. Article

> Boehringer Ingelheim has chosen Kuehne + Nagel to management temperature-controlled transportation in the Czech Republic, Poland, Hungary, Greece and Croatia. Release

> Simcere Pharmaceutical's Jiangsu Yanshen Biological has been fined $3.74 million by the Changzhou Food and Drug Administration for production of substandard human rabies vaccine, plus $3.36 million to cover the cost of patient re-vaccinations. Release